 |
PDBsum entry 2fk3
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Metal binding protein
|
PDB id
|
|
|
|
2fk3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Metal binding protein
|
 |
|
Title:
|
 |
Structure of the alzheimer's amyloid precursor protein (app) copper binding domain in 'large unit cell' form
|
|
Structure:
|
 |
Amyloid beta a4 protein precursor. Chain: a, b, c, d, e, f, g, h. Fragment: residues 133 to 189. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: app. Expressed in: pichia pastoris. Expression_system_taxid: 4922.
|
|
Resolution:
|
 |
|
2.40Å
|
R-factor:
|
0.208
|
R-free:
|
0.248
|
|
|
Authors:
|
 |
G.K.-W.Kong,M.W.Parker
|
Key ref:
|
 |
G.K.Kong
et al.
(2007).
Structural studies of the Alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper ions.
J Mol Biol,
367,
148-161.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
04-Jan-06
|
Release date:
|
16-Jan-07
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P05067
(A4_HUMAN) -
Amyloid-beta precursor protein from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
770 a.a.
59 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 2 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
367:148-161
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural studies of the Alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper ions.
|
|
G.K.Kong,
J.J.Adams,
H.H.Harris,
J.F.Boas,
C.C.Curtain,
D.Galatis,
C.L.Masters,
K.J.Barnham,
W.J.McKinstry,
R.Cappai,
M.W.Parker.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Alzheimer's disease (AD) is the major cause of dementia. Amyloid beta peptide
(Abeta), generated by proteolytic cleavage of the amyloid precursor protein
(APP), is central to AD pathogenesis. APP can function as a metalloprotein and
modulate copper (Cu) transport, presumably via its extracellular Cu-binding
domain (CuBD). Cu binding to the CuBD reduces Abeta levels, suggesting that a Cu
mimetic may have therapeutic potential. We describe here the atomic structures
of apo CuBD from three crystal forms and found they have identical Cu-binding
sites despite the different crystal lattices. The structure of Cu(2+)-bound CuBD
reveals that the metal ligands are His147, His151, Tyr168 and two water
molecules, which are arranged in a square pyramidal geometry. The site resembles
a Type 2 non-blue Cu center and is supported by electron paramagnetic resonance
and extended X-ray absorption fine structure studies. A previous study suggested
that Met170 might be a ligand but we suggest that this residue plays a critical
role as an electron donor in CuBDs ability to reduce Cu ions. The structure of
Cu(+)-bound CuBD is almost identical to the Cu(2+)-bound structure except for
the loss of one of the water ligands. The geometry of the site is unfavorable
for Cu(+), thus providing a mechanism by which CuBD could readily transfer Cu
ions to other proteins.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. The structure of CuBD[133-189] in Type A crystal
form. This ribbon diagram of apo CuBD[133-189] is shown in
stereo view and prepared using BOBSCRIPT.^63 Key residues
surrounding the Cu-binding pocket are shown in ball-and-stick.
|
 |
Figure 4.
Figure 4. The coordination geometry of Cu^2+ and Cu^+ in CuBD
and comparison against the apo Type A structure. (a) The Cu^2+
binding geometry in CuBD[133-189]. The ligands are labeled (eq
and ax denote the equatorial and axial water molecules). (b) A
comparison of the Cu-binding site in the presence (atomic
coloring) and absence (grey, apo form) of the Cu^2+. (c) The
Cu^+ binding geometry in CuBD[133-189]. (d) A comparison of the
Cu-binding site in the presence (atomic coloring) and absence
(grey, apo form) of the Cu^+. All panels are in stereo view. The
orange sphere represents the Cu^2+ in (a) and (b) or Cu^+ in (c)
and (d). The red spheres are water molecules. The
2F[obs]–F[calc] electron density is shown in (a) and (c) in
blue mesh and contoured at 1σ level. All Figures were prepared
using the program PyMol (DeLano Scientific LLC, San Carlos, CA).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2007,
367,
148-161)
copyright 2007.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.G.Botelho,
X.Wang,
D.J.Arndt-Jovin,
D.Becker,
and
T.M.Jovin
(2010).
Induction of terminal differentiation in melanoma cells on downregulation of beta-amyloid precursor protein.
|
| |
J Invest Dermatol,
130,
1400-1410.
|
 |
|
|
|
|
 |
S.O.Dahms,
S.Hoefgen,
D.Roeser,
B.Schlott,
K.H.Gührs,
and
M.E.Than
(2010).
Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein.
|
| |
Proc Natl Acad Sci U S A,
107,
5381-5386.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.R.Brown
(2009).
Brain proteins that mind metals: a neurodegenerative perspective.
|
| |
Dalton Trans,
(),
4069-4076.
|
 |
|
|
|
|
 |
W.H.Suh,
K.S.Suslick,
G.D.Stucky,
and
Y.H.Suh
(2009).
Nanotechnology, nanotoxicology, and neuroscience.
|
| |
Prog Neurobiol,
87,
133-170.
|
 |
|
|
|
|
 |
C.Aisenbrey,
T.Borowik,
R.Byström,
M.Bokvist,
F.Lindström,
H.Misiak,
M.A.Sani,
and
G.Gröbner
(2008).
How is protein aggregation in amyloidogenic diseases modulated by biological membranes?
|
| |
Eur Biophys J,
37,
247-255.
|
 |
|
|
|
|
 |
G.K.Kong,
L.A.Miles,
G.A.Crespi,
C.J.Morton,
H.L.Ng,
K.J.Barnham,
W.J.McKinstry,
R.Cappai,
and
M.W.Parker
(2008).
Copper binding to the Alzheimer's disease amyloid precursor protein.
|
| |
Eur Biophys J,
37,
269-279.
|
 |
|
|
|
|
 |
J.F.Boas,
S.C.Drew,
and
C.C.Curtain
(2008).
Applications of electron paramagnetic resonance to studies of neurological disease.
|
| |
Eur Biophys J,
37,
281-294.
|
 |
|
|
|
|
 |
K.J.Barnham,
and
A.I.Bush
(2008).
Metals in Alzheimer's and Parkinson's diseases.
|
| |
Curr Opin Chem Biol,
12,
222-228.
|
 |
|
|
|
|
 |
M.A.Brooks,
L.Meslet-Cladiére,
M.Graille,
J.Kuhn,
K.Blondeau,
H.Myllykallio,
and
H.van Tilbeurgh
(2008).
The structure of an archaeal homodimeric ligase which has RNA circularization activity.
|
| |
Protein Sci,
17,
1336-1345.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.W.Strange,
and
M.C.Feiters
(2008).
Biological X-ray absorption spectroscopy (BioXAS): a valuable tool for the study of trace elements in the life sciences.
|
| |
Curr Opin Struct Biol,
18,
609-616.
|
 |
|
|
|
|
 |
D.Huster,
and
S.Lutsenko
(2007).
Wilson disease: not just a copper disorder. Analysis of a Wilson disease model demonstrates the link between copper and lipid metabolism.
|
| |
Mol Biosyst,
3,
816-824.
|
 |
|
|
|
|
 |
G.K.Kong,
J.J.Adams,
R.Cappai,
and
M.W.Parker
(2007).
Structure of Alzheimer's disease amyloid precursor protein copper-binding domain at atomic resolution.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun,
63,
819-824.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Gralle,
and
S.T.Ferreira
(2007).
Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts.
|
| |
Prog Neurobiol,
82,
11-32.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |